Decoding DOJ’s Crackdown on Genetic Testing: High-Profile Indictments and Practical Takeaways for the Cancer and Pharma Genomics Industries
- March 20, 2020
- Giovanni P. Giarratana , Bradley Arant Boult Cummings LLP
- Somadina I. Nwokolo , Bradley Arant Boult Cummings LLP
In the advent of DNA testing, companies such as Ancestry.com and 23andMe have made it easy and convenient to submit DNA samples for testing from your own home. This type of genetic—also known as genomic—testing has been applied to a variety of uses, including paternity determinations and the discovery of genetic ancestors and relatives. It is no overstatement to note that genetic testing has also revolutionized the health care industry, making it possible to asses a person’s risk of developing certain genetic diseases and response to certain types of treatments.
ARTICLE TAGS
You must be logged in to access this content.